About Kailos
Kailos is a Healthcare company based in Huntsville (United States) founded in 2010, and was acquired by HealthOme in June 2023. Provider of consumer-based genetic testing services. Kailos has raised $3.9 million across 4 funding rounds from investors including NIH, healthŌme and In-Q-Tel. The company has 10 employees. Kailos offers products and services including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Consumer Genomics. Its legal entity is KAILOS GENETICS, INC. Its competitors include Helix, Color and Veritas Genetics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 and headquartered in Huntsville, United States, operations in the biotechnology sector are focused on consumer genetic testing. Clinical-grade assays and next-generation sequencing are utilized to deliver actionable genetic insights. Services encompass cancer testing, pharmacogenetic analysis, and research support, enabling personalized health information for individuals and studies.
- Headquarters Huntsville, United States
- Employees 10
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website kailosgenetics.com
- Social LinkedIn X Facebook
- Acquired by HealthOme (Jun 2023)
- Legal Name Kailos Genetics, Inc.
Products & Services of Kailos
Kailos offers a comprehensive portfolio of products and services, including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services.
Customizable panels for integrating into laboratory workflows.
Technology for enhanced genetic sequencing and analysis.
Complete kits for genetic research and data analysis.
Funding Insights of Kailos
Kailos has successfully raised a total of $3.9M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.9M
- Total Rounds 4
- Last Round Series B — $2M
- First Round $1.9M
(Dec 2011)
- Investors Count 2
All 4 funding rounds of Kailos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Kailos
Kailos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, healthŌme and In-Q-Tel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm | iqt.org | Washington, Dc, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Genetic testing and support services for cancer risks are provided. | 2021 | healthome.com | Huntsville, United States |
Investor details for Kailos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kailos
7 people are tracked at Kailos (5 in leadership, 2 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Ron McGlennen | Medical Director | Leadership |
Brian Pollock | CEO & Founder | Leadership |
David Kloske | VP of Informatics & Chief Technology Officer | Leadership |
Randy Bachmeyer | Chief Technology Officer | Leadership |
Irina Vasenkova PhD, HCLD/TS(ABB) | Clinical Laboratory Assistant Director | Leadership |
Thomas Ryan May | Purchasing and Logistics Manager | Team |
Sarah Landrum, MLS(ASCP)CM | Clinical Laboratory Technologist I | Team |
Complete people profiles for Kailos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kailos
4 dated milestones of Kailos across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Kailos is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Series B, of $2.0M.
- Exit Acquired by HealthOme.
Competitors of Kailos
Kailos has 3 listed competitors in our database, 3 of them funded. They include Helix, Color and Veritas Genetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. |
Detailed competitors of Kailos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kailos
The website of Kailos (kailosgenetics.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 11.8% vs previous month
Websites whose visitors overlap most with Kailos. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genomind.com | 100% | 64.1K | #547,972 | View details | |
| medscape.com | 96% | 8.5M | #7,566 | View details | |
| lifelength.com | 90% | View details | |||
rarechromo.org | rarechromo.org | 89% | #559,777 | – | |
| goodstartgenetics.com | 88% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Kailos
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Kailos (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kailos
Complete news archive for Kailos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kailos
Kailos was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Kailos is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.
Kailos is a funded company, having raised a total of $3.9M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1.9M, raised on Dec 2011.
Kailos has 10 employees.
Founded in 2010 and headquartered in Huntsville, United States, operations in the biotechnology sector are focused on consumer genetic testing. Clinical-grade assays and next-generation sequencing are utilized to deliver actionable genetic insights. Services encompass cancer testing, pharmacogenetic analysis, and research support, enabling personalized health information for individuals and studies.
Kailos's top competitors include Helix, Veritas Genetics and Color.
Kailos offers Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services.
Kailos operates through Kailos Genetics, Inc..
Yes. Kailos was acquired by HealthOme in June 2023.